Build the release case before the batch is finished
Release work starts with the requirements for this product, site and destination. Seal brings the executed batch record, material genealogy, laboratory evidence and quality reviews into one case. Each requirement has an owner, a source and a recorded outcome. Teams can see which work is complete, which evidence is missing and which decision is holding the batch.
Begin with your approved release procedure. Define the population, applicable specification, manufacturing instructions, sampling plan, review roles and market conditions. Keep the effective versions with the case. A reviewer should be able to explain why a requirement applies to this batch without reconstructing the plan from separate files.
Assemble the evidence
Manufacturing execution and genealogy, approved QC results, quality investigations and impact decisions.
Resolve the release review
Keep scope, source versions and reviewers together. Return open requirements to their owners.
Record QA disposition
The authorised role records the decision, its evidence and its exact scope.
Apply the downstream controls
Inventory and the CoA follow the decision. Distribution also checks the destination: M2 is eligible; M1 awaits authority acknowledgement.
Give each blocker a source and an owner
B-071 has three reviewed laboratory results and an unresolved hold-time exception. Its release case connects the 52-minute observation, the 45-minute instruction limit, the deviation and the required product-impact assessment. The quality reviewer can follow the issue to its source; the production reviewer can see the conclusion needed to complete manufacturing review.
The same approach applies to a missing signature, preliminary result, unapproved substitution or incomplete source-data review. Keep the reason, responsible role, linked evidence and next action together. A review queue should tell the team what to do next, while retaining all required checks, including those already complete.
Review the evidence that was true at execution
Manufacturing review needs the instruction version used, actual values, calculations, material lots, equipment, people, times, corrections and signatures. Laboratory review needs sample identity, the applicable specification and method, suitability, reportable results and their approval. A preliminary passing value does not satisfy a requirement for an approved result.
Equipment, cleaning and personnel checks concern the time and purpose of use. A balance being calibrated today does not establish its state when the batch ran. Keep the relevant eligibility evidence with the recorded use, and link any later investigation to the batches it may affect. Preserve original results and invalidation history when a replacement result is generated.
Review as evidence arrives, with a clear path for changes
Manufacturing, QC and QA can review completed evidence while later activities continue. Retain each review's scope, source versions and outcome, so the final reviewer can distinguish work already assessed from new information. Configure which corrections, new results or linked deviations require reassessment, then verify that path before use.
For short-shelf-life products, include expected result availability, review handoffs and the latest decision time in the plan. The team can work on the actual critical path. Any conditional or exceptional release path still requires the applicable approved procedure, evidence and authorised decision; the schedule alone does not resolve a missing requirement.
Record precisely what QA decided
In the second example stage, the impact assessment is approved and manufacturing review is complete. That makes the case ready for the authorised release role. The disposition records the defined batch population, quantity, presentation, evidence reviewed, rationale, conditions, signature meaning and effective time. Completion of the preceding reviews leaves that decision with QA.
A release, rejection, restriction or further-evaluation outcome must carry its own scope. When an authorised amendment is needed, preserve the previous decision and the reason for the change. A reviewer returning later should be able to reconstruct the evidence considered and the decision made at that point, including any approved outstanding conditions.
Carry the decision into stock, markets and certificates
A manufacturer disposition and permission to distribute to a destination can differ. In the final illustrative stage, B-071 is eligible for Market M2 while Market M1 still awaits authority acknowledgement. Keep the market condition visible alongside the signed disposition. Configure inventory and distribution controls to apply the intended population and destination scope.
Prepare the certificate of analysis from the approved product, specification and reportable result versions. Retain certificate review, issue and replacement history. Reconcile the disposition, stock transition, applicable market gates, certificate and required notifications before closing the case. Each downstream record should lead back to the decision that supports it.
Start with one difficult batch
Bring an approved release procedure and a representative batch with a real review problem. Scope the source systems, release requirements and responsible teams. Use neil to prepare the evidence index and proposed review work; have the team review the configuration and verify the release path against its intended use.
Prove the awkward cases as well as the completed case: a preliminary result, a changed reviewed record, an unresolved impact assessment, an unauthorised completion attempt and a destination that remains blocked after QA disposition. Agree which record owns each decision and how stock and certificates consume it. That gives the first workflow a concrete acceptance boundary.
Connect batch execution, QC laboratory work, deviation assessment, inventory and certificates of analysis around the same release case.